Skip to main content
SpringerLink
Log in

Clinical efficacy in depression

  • Chapter
St. John’s Wort and its Active Principles in Depression and Anxiety

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

  • 1013 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19

    PubMed  Google Scholar 

  2. World Health Organization (1998) Health 21 — the Health for All Policy for the WHO European Region — 21 Targets for the 21st Century (EUR/RC4810). World Health Organization, Geneva

    Google Scholar 

  3. Gupta RK, Möller HJ (2003) St. John’s Wort. An option for the primary care treatment of depressive patients? Eur Arch Psychiatry Clin Neurosci 253: 140–148

    Article  PubMed  Google Scholar 

  4. Kasper S, Trautmann-Sponsel RD (2001) St. John’s Wort extract: an effective and well-tolerated antidepressant. Primary Care Psychiatry 7: 39–42

    Article  Google Scholar 

  5. Laakmann G, Jahn G, Schüle C (2002) Hypericum perforatum Extrakt bei der Behandlung leichter bis mittelschwerer Depressionen. Klinische und pharmakologische Aspekte. Der Nervenarzt 73: 600–612

    Article  PubMed  Google Scholar 

  6. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996) St. John’s Wort for depression — an overview and meta-analysis of randomized clinical trials. BMJ 313: 253–258

    PubMed  Google Scholar 

  7. Linde K, Mulrow CD (1998) Review: St. John’s Wort for depression. The Cochrane Library 4: 1–15

    Google Scholar 

  8. Linde K, Mulrow CD (2004) St. John’s Wort for depression (Cochrane Review). The Cochrane Library, Issue 2, 2004. John Wiley and Sons, Ltd, Chichester, UK

    Google Scholar 

  9. Maurer A, Johne A, Bauer S et al. (1999) Interaction of St. John’s Wort extract with phenpro-coumon. Eur J Clin Pharmacol 55: A22 (Abstr 79)

    Google Scholar 

  10. Schulz V, Hänsel R (1999) Rationale Phytotherapie. Ratgeber für die ärztliche Praxis. Springer, Heidelberg

    Google Scholar 

  11. Volz HP (1997) Controlled clinical trials of Hypericum extracts in depressed patients: An overview. Pharmacopsychiatry 30(Suppl): 72–76

    Google Scholar 

  12. Kalb R, Trautmann-Sponsel RD, Kieser M (2001) Efficacy and tolerability of Hypericum extract WS® 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 34: 96–103

    Article  PubMed  Google Scholar 

  13. Lecrubier Y, Clerc G, Didi R, Kieser M (2002) Efficacy of St. John’s Wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry: 1361–1366

    Google Scholar 

  14. Kasper S, Dienel A (2002) Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 164: 301–308

    Article  PubMed  Google Scholar 

  15. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R et al. (2001) Effectiveness of St. John’s Wort in major depression. A randomized controlled trial. JAMA 285: 1978–1986

    Article  PubMed  Google Scholar 

  16. Davidson JRT on behalf of the Hypericum Depression Trial Study Group (2002) Effect of Hypericum perforatum (St. John’s Wort) in major depressive disorder. JAMA 287: 1807–1814

    Article  PubMed  Google Scholar 

  17. Rychlik R, Siedentop H, von den Driesch V, Kasper S (2001) Johanniskraut WS 5572 bei leichten bis mittelschweren Depressionen. Wirksamkeit und Verträglichkeit von 600 und 1200 mg Wirkstoff täglich. Fortschritte der Medizin 119: 119–128

    PubMed  Google Scholar 

  18. Vorbach EU, Arnoldt KH, Mannel M (2000) Johanniskraut als Phyto-Antidepressivum. Fundamenta Psychiatrica 14: 172–180

    Google Scholar 

  19. Roots I (1999) Arzneimittel-Interaktionen mit Johanniskraut. Gutachten für das BfArM vom 1.12.1999

    Google Scholar 

  20. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St. John’s Wort. Clin Pharmacol Ther 66: 338–345

    PubMed  Google Scholar 

  21. Ernst E (1999) Second thoughts about safety of St. John’s Wort. Lancet 354: 2014–2016

    PubMed  Google Scholar 

  22. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J (2000) Indinavir concentrations and St. John’s Wort. Lancet 355: 547–548

    PubMed  Google Scholar 

  23. Laakmann G, Schüle C, Baghai T (1998) St. John’s Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31(Suppl. 1): 54–59

    PubMed  Google Scholar 

  24. Kalb R, Arnoldt KH, Kleemann A (2000) Langzeitbehandlung mit Johanniskraut-Extrakt LI 160. Ergebnisse einer offenen multizentrischen Therapiestudie zur Wirksamkeit und Verträglichkeit über 12 Monate bei Patienten mit depressiven Erkrankungen. Der Allgemeinarzt 16: 428–433

    Google Scholar 

  25. Kasper S, Dienel A, Kieser M (2004) Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression — Rationale and study design. Int J Methods Psychiatr Res 13: 176–183

    PubMed  Google Scholar 

  26. Sommer H, Harrer G (1994) Placebo-controlled double blind study examining the effectiveness of a Hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 7(Suppl 1): S9–S11

    PubMed  Google Scholar 

  27. Hübner WD, Lande S, Podzuweit H (1994) Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol 7(Suppl 1): S12–S14

    PubMed  Google Scholar 

  28. Hänsgen KD, Vesper J, Ploch M (1994) Multicentre double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. J Geriatr Psychiatry Neurol 7(Suppl 1): S15–S18

    PubMed  Google Scholar 

  29. Bjerkenstedt L (2000) Studie mit Johanniskraut-Extrakt LI 160 bei leichten bis mittelschweren Depressionen. Äquipotente Wirkung im Vergleich mit einem synthetischen Antidepressivum gezeigt. Ärzte Zeitung 18 (März), Sonderdruck Nr. 226

    Google Scholar 

  30. Montgomery SA, Hübner WD, Grigoleit HG (2000) Efficacy and tolerability of St. John’s Wort extract compared with placebo in patients with a mild to moderate depressive disorder. Phytomedicine 7(Suppl II): 107

    Google Scholar 

  31. Schrader E, Meier B, Brattström A (1998) Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 13: 163–169

    Google Scholar 

  32. Philipp M, Kohnen R, Hiller KO (1999) Hypericum extract versus Imipramine or placebo in patients with moderate depression. Randomised multicenter study of treatment for eight weeks. Brit Med J 319: 1534–1538

    PubMed  Google Scholar 

  33. Harrer G, Schmidt U, Kuhn U, Biller A (1999) Comparison of equivalence between St. John’s Wort extract LoHyp-57 and Fluoxetine. Arzneimittel-Forschung/Drug Research 49: 289–296

    Google Scholar 

  34. Schrader E (2000) Equivalence of St. John’s Wort extract (ZE 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 15: 61–68

    PubMed  Google Scholar 

  35. Woelk H (2000) Comparison of St. John’s Wort and imipramine for treating depression: randomised controlled trial: Brit Med J 321: 536–539

    PubMed  Google Scholar 

  36. Volz HP, Laux P (2000) Potential treatment for subthreshold and mild depression: a comparison of St. John’s Wort extracts and fluoxetine. Compr Psychiatry 41(Suppl 1): 133–137

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Austria

    Siegfried Kasper

Authors
  1. Siegfried Kasper
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut für Naturwissenschaftler, Biozentrum Universität Frankfurt, Marie-Curie-Str.9, 60439, Frankfurt, Germany

    Walter E. Müller

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Kasper, S. (2005). Clinical efficacy in depression. In: Müller, W.E. (eds) St. John’s Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7338-5_10

Download citation

Publish with us

Policies and ethics

Search

Navigation